# Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)

> **NCT03983980** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 515 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** Tapinarof
- **DRUG:** Vehicle Cream

## Key facts

- **NCT ID:** NCT03983980
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-06
- **Primary completion:** 2020-05-13
- **Final completion:** 2020-05-29
- **Target enrollment:** 515 (ACTUAL)
- **Last updated:** 2025-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03983980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03983980, "Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03983980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*